ArticleJCI insight2016
PRL3-zumab, a first-in-class humanized antibody for cancer therapy.
Min Thura et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
41 papers cite it
this papertrialcites it
ArticleJCI insight2016
Min Thura et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.